Risperdal Settlement Amounts

Recent Risperdal Settlements

The makers of Risperdal have settled with the Department of Justice in 2013 for over 2.2 Billion Dollars. Currently they are settling with the States, and the Risperdal Settlement amounts are staggering. There is no doubt that people that were affected by the drug Risperdal will be next in line for a Risperdal Settlement. The Big question is what will the Risperdal Settlement amounts be.

Risperdal Belwether trials have yielded verdicts for the victims of 2.5 million, 1.75 million, and 500,000 thousand dollars. These trials help create a matrix for the Risperdal Settlement. What will happen next is that after intense negotiations between the attorneys on the Plaintiff Steering Committee,  and the attorneys for Johnson and Johnson, a Settlement will be reached.

Expect the Risperdal Settlement to have a graduated curve to it. For example an adolescent who developed gynoclamastia, and had breast reduction surgery will receive more then an adult who has gynoclamastia but did not have surgery.

We have heard from some members of the Plaintiff Steering Committee and the Risperdal Settlement amounts are much larger then they originally anticipated.

We have been told and mind you this is complete conjecture until the Risperdal Settlement is announced that people  specifically adolescents that had breast reduction surgery could see settlements between $800,000-1.2 million dollars.

The key here is that they had breast reduction surgery, many have had liposuction, and the younger you were when the surgery occurred the higher your award.

Possible Risperdal Settlement Amounts

We have also heard that people, specifically adults that suffered from gynoclamastia but have not had surgery would see between $100,000 to $200,000 dollars. Again keep in mind these numbers are pure conjecture at this point, but in speaking with different members of the Plaintiff Steering Committee there does seem to be a consensus.

In our estimation we will see a Risperdal Settlement in the very near future.

If you or a loved one took the drug Risperdal, please call us at 1-888-366-9595.

Risperdal Settlement Amounts

Risperdal Settlement Amounts Revised

Recent developments in the Risperdal Settlement include a $2.5 million dollar verdict out of Philadelphia, this occurred on 2/25/15.

This has spawned an onslaught of attorney advertising, and possibly expanded the scope of the Risperdal Settlement

The potential Risperdal Settlement amounts may have increased almost two fold.

It also seems as though men who took Risperdal will also be covered, not just males under the age of 18.

Risperdal causes gynecomastia, which is the enlargement of the male breast, at this point in time the Risperdal settlement is only for males.

It is thought by certain members of the Risperdal P.S.C which controls the Risperdal Settlement for those affected by Risperdal. That the bellwether trials yet to come will be more bad news for Johnson and Johnson.

Johnson and Johnson have already had to pay 2.2 Billion dollars to the Department of Justice as the J&J Subsidiary Janssen Pleaded Guilty to Misbranding the Antipsychotic Drug.

As I was writing this I just spoke to a distinguished member of the Plaintiffs Steering Committee that told me they have over 30 million documents that establish a string of deception by Jansen and Johnson and Johnson.

Johnson and Johnson have a history of coming to quick settlements if it can be found that they were grossly negligent. We believe that there is a very good chance that will be the case here.

Mind you, nobody knows for sure what Risperdal Settlements amounts will be, but with the new developments, this is looking more like the breakdown.

Revised Risperdal Settlement Amounts.

$100,000-$200,000it is expected for a man who suffers from gynecomastia.

$400,000-$600,000 if you had revision surgery such as liposuction.

Call Us for More information 1-888-366-9595

Risperdal Gynecomastia Causes Depression Symptoms

Johnson and Johnson is currently still involved in litigation regarding one of their premiere drugs, Risperdal, and the medical links that have been made between this drug and gynecomastia or male breast growth. The litigation stems from this drug being marketed to children without FDA approval, which is very illegal and unethical, this drug was given to children while the side effects had not yet been tested for patients that young. In many of these cases, especially teenage boys, Risperdal gynecomastia was formed and is unable to be resolved with out costly corrective surgery or intensive testosterone treatment. Often times these surgeries are considered cosmetic and are not covered by many insurance companies and also may cost up to $3,500 out of pocket. As risperdal is one of the few antipsychotics that is covered by medicaid and though this surgery may seem like it is at the lower end of the cost spectrum, will likely remain out of reach for most of these patients. Especially considering these growths are an effect from a medicine that they were prescribed to help them, not ruin their lives.

The issue of Risperdal gynecomastia is very real and it is being found that many of these cases are having other than physical symptoms associated with this side effect. Teenage boys are having enough issues dealing with puberty, though they are growing up, they are still children and many of them may not have the capacity to handle all of this added stress. Not to mention the social ramifications of a teenage boy walking the halls of a high school with breasts, as it is common knowledge that bullying is very real in schools and has even been expanded with the premiere of social media less than 10 years ago. These are our children that are being tormented by the public and also by themselves. They are going through such a personal issue, yet they receive no understanding from their peers and often times their parents. It is not as though there are Risperdal gynecomastia support groups that are readily available as it is a fairly common, yet misunderstood ailment, so there they are left alone with nothing but their negative thoughts about themselves.

There is a light at the end of the tunnel for these patients suffering with Risperdal gynecomastia. As of September 2014, there were just over 600 plaintiffs involved in this litigation and the number is increasing by the day. The settlement at that point was looking to be about $2.2 billion dollars and if that was split evenly with this low amount of plaintiffs, that would be just over $3.6 million a piece. As this is settlement is still under negotiation and the plaintiffs are coming into the light more and more, this number will likely change, but one thing is for sure, Johnson and Johnson is not going to be getting off easy in the least as far as accountability is concerned.

Our attorneys at Band Gates & Dramis are here to support you and your family. Just concentrate on your recovery and don’t worry about payment until you receive your settlement. For a FREE consultation either fill out this form to the right or call us today.

Risperdal Lawsuit Help

1-888-366-9595

Risperdal Statute of Limitations

Risperdal Gynecomastia

If you have been affected by Risperdal gynecomastia, you may be eligible for a claim in the Risperdal lawsuit.

As you may already know, there is now accumulating scientific evidence showing the link between Risperdal and the swelling of breast tissue in males.

Taking Risperdal can cause elevated levels of a hormone called prolactin. Prolactin is normally found in expectant and breast feeding mothers, and aids in the lactation process in breastfeeding.

However, when prolactin levels are abnormally high in males, this can cause the swelling of breast tissue, which can result in male breasts. This can be painful and embarrassing for the often young men taking Risperdal.

Risperdal Illegally Marketed to Children

The Risperdal statute of limitations is really unfortunate for some, and here’s why:

Risperdal was released to be sold for public use in 1993. At the time, it only had FDA approval to be used for adults with schizophrenia.

It wasn’t until 2006 that Risperdal became approved for any use with children, and that was for the treatment of the irritability associated with autism spectrum disorders in children aged 5-17.

In 2007 Risperdal was approved for the treatment of psychosis related to schizophrenia in adolescents aged 13-17, and mania from bipolar disorder in kids aged 10-17.

However, Risperdal was being prescribed to children long before the FDA approval.

Doctors and healthcare providers are allowed to make “judgement calls” when they feel a medicine might help, and prescribe it for non-approved, of off-label uses.

Risperdal was prescribed to children many years before the FDA ever gave approval for it.

But the intentions of some of these doctors and institutions are questionable, as Risperdal manufacturer, Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, illegally marketed the drug for use with children.

In addition, it has been proven in a court of law that Janssen bribed doctors to prescribe the drug.

Not only did Janssen illegally market the drug to children, they were involved in a scam of providing illegal incentives to doctors and pharmaceutical companies to prescribe their drug.

As a result of Janssen’s misconduct, many children were prescribed Risperdal prematurely, before there were proper safety testing procedures and clinical trials.

Now that Risperdal has been approved for some use in children, studies are being published showing that Risperdal can cause hormonal imbalance, and the painful swelling of male breast tissue leading to Risperdal gynecomastia.

Risperdal Statute of Limitations

The statute of limitations is different in each state, but is impacting the Risperdal lawsuit.

Some states start the Risperdal statute of limitations from the day a person was diagnosed with gynecomastia, others start the Risperdal statute of limitations from the first time the breast swelling occurred or was noticed by the individual.

The problem is, the children who were prematurely prescribed Risperdal before the FDA approval may have experienced Risperdal gynecomastia and never knew it.

Gynecomastia sometimes occurs during puberty all on its own. But gynecomastia occurs at a much higher rate when the young adolescent is taking Risperdal.

Thus, these children may have experienced Risperdal gynecomastia, and all the problems associated with it and never even knew.

Until now.

Now, science is pouring in on the adverse Risperdal side effects, including Risperdal gynecomastia.

However, for those who were prematurely prescribed Risperdal 10 or 15 years ago, the statute of limitations may have already run out.

Statute of limitation sanctions vary greatly state by state; it is recommended that you seek the counsel of a Risperdal lawyer to determine if you are affected by the Risperdal statute of limitations. We can help you with this, at no charge.

It’s important that if you have a claim, you start the Risperdal claims process immediately.

At Band Gates & Dramis we pride ourselves in the expedition of the Risperdal claims process, getting your claim to the best Risperdal lawyer available, and ensuring it gets the attention it deserves.

We offer a free, no obligation consultation. If your claims becomes a part of the Risperdal lawsuit, our attorneys do not charge a fee until you collect a fair Risperdal settlement.

Don’t let time pass, as the Risperdal statute of limitations may be approaching.

Call Band Gates & Dramis Attorneys to get started on your Risperdal lawsuit today.

Risperdal Lawsuit Help

1-888-366-9595

Risperdal Gynecomastia Lawsuit Introduction

In this article we will introduce Risperdal, gynecomastia, and the Risperdal lawsuit. The Risperdal lawsuit is complicated, and we encourage you to learn as much as possible about this litigation.

At Band Gates & Dramis we are attorneys, here to help. If you have any questions, or feel you may have a Risperdal lawsuit claim, don’t hesitate to call this number to speak with a live representative:

1-888-366-9595

What is Risperdal?

Risperdal is a psychiatric medication, belonging to the class of atypical antipsychotics, also known as second generation antipsychotics.

Risperdal is a brand name of its generic form risperdone.

Risperdal was originally FDA approved for the treatment of schizophrenia in adults in 1993.

Over the years, Risperdal has received additional FDA approval for other uses.

It is also now available for the treatment of acute manic episodes in bipolar disorder for people aged 10 and up, schizophrenia in adolescents 13-17 years old, and for the irritability associated with autism spectrum disorders for children aged 5-17.

It is manufactured and sold by Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson.

Risperdal works by affecting brain chemistry. It interferes with certain neurotransmitters, namely serotonin and dopamine.

Neurotransmitters are chemicals used to the brain to facilitate communication between the brain cells, which are called neurons.

The human brain is still largely a mystery to scientists, and little is known conclusively about how psychiatric drugs such as Risperdal work.

We know that Risperdal blocks the neurotransmitters dopamine and serotonin, restoring a chemical balance in the brain. This balance results in desirable psychological or behavioral changes.

Risperdal is one of Janssen’s best selling drugs, and has brought in billions of dollars in profits for this pharmaceutical corporation.

Risperdal Gynecomastia Lawsuit Introduction

As with all pharmaceutical medications, Risperdal can cause side effects.

However, there is one side effect many Risperdal users were not anticipating: Risperdal gynecomastia.

In males, Risperdal can cause the swelling of breast tissue. This swelling of tissue can be very painful, and can lead to the development of male breasts. This condition may happen on one or both sides of the chest, and does not always occur evenly.

This is a condition known as gynecomastia.

In some cases, Risperdal gynecomastia can even lead to nipple lactation.

Risperdal gynecomastia is caused by an imbalance of male and female hormones.

Studies have shown that Risperdal causes elevated levels of a female hormone called prolactin. Normally, prolactin is used to help with the lactation process in breastfeeding mothers.

In males, high levels of prolactin can lead to the swelling of breast tissue, a clinical condition known as gynecomastia.

Risperdal gynecomastia causes embarrassment, social problems, and other adverse or negative psychological effects.

In adolescents, gynecomastia has been shown to adversely affect a boy’s eating habits, social functioning, self-esteem, as well as other aspects of their mental and physical health.

Risperdal gynecomastia sometimes goes away on its own. Treatment for Risperdal gynecomastia can include hormone therapy or surgery to remove the swollen breast tissue.

Risperdal Lawsuits

Risperdal is in the legal hot seat, as several different Risperdal lawsuits and claims have been filed.

Several Risperdal lawsuits have already been settled.

There have been many different types of Risperdal lawsuits.

Janssen Pharmaceuticals previously settled in federal court for $2.2 billion for illegally marketing and promoting the drug.

The Risperdal gynecomastia lawsuits are civil actions, in which individuals who have experienced Risperdal gynecomastia are filing individual claims. The Risperdal lawsuit is not technically a class action lawsuit, and it will likely be organized as a multidistrict litigation.

Claimants in the Risperdal lawsuit allege that they experienced gynecomastia as a direct result of taking Risperdal.

Furthermore, Janssen Pharmaceuticals failed to warn them about this Risperdal side effect.

Many Risperdal gynecomastia lawsuits have already been filed with success, resulting in Risperdal settlements.

Risperdal settlements are monetary compensation the claimant receives when their Risperdal lawsuit is won. Claimants in the Risperdal lawsuit are suing for medical bills, loss of wages, pain and suffering, and other damages.

Many of the victims of Risperdal gynecomastia had to have corrective surgery, a painful, dangerous, and expensive result of the Risperdal side effects.

If you have been affected by Risperdal gynecomastia, you may be eligible to make a claim in the Risperdal lawsuit.

We can help. We are Reich & Binstock, and we are here to serve.

We are consumer advocates who assist injured parties get justice.

The time to act is now, as the Risperdal lawsuit is in court, and there may be a Risperdal statute of limitations in place.

We offer a free consultation for your Risperdal claim. We are here to teach you all about the Risperdal lawsuit, process your claim, and connect you with a major Risperdal lawyer working on the case.

Our Risperdal attorneys will fight tirelessly for your claim, so you can focus on healing. They do not collect a fee until you collect a Risperdal settlement.

Feel free to check out our other articles on this page, as we are following the Risperdal lawsuit closely and know that an informed consumer is the best kind.

Risperdal Lawsuit Help

1-888-366-9595

New Study On Risperdal Gynecomastia

The Risperdal Disaster

As one of Janssen Pharmaceutical’s best selling drugs, Risperdal prescriptions are estimated to be filled 12 million times a year in the United States.

But the history behind this antipsychotic drug is one full of scandal, deception, and harm to the public.

Initially approved for sale in 1993, Risperdal is a second generation antipsychotic prescribed for psychological issues including schizophrenia, manic episodes in bipolar disorder, and for the treatment of irritability in children with autism spectrum disorders.

Risperdal is the brand name of the generic drug risperdone.

The manufacturer of Risperdal, Janssen Pharmaceuticals Inc., marketed it aggressively, often for unapproved or “off-label” uses.

Additionally, Janssen has been found guilty of providing illegal incentives to healthcare providers to prescribe this drug.

Given the lengthy history of unethical business practices revolving around Risperdal, it is no surprise that Risperdal has now been found to cause side effects users and physicians were not made aware of – side effects Janssen kept hidden.

Risperdal causes gynecomastia, a condition in which male breast tissue swells, often painfully, leading to the development of male breasts. This can cause physical and psychological trauma to the individual, and sometimes has to be surgically corrected.

The occurence of Risperdal gynecomastia is so high that it is suspicious that Janssen Pharmaceuticals did not seem to notice this severe Risperdal side effect in their pre-market clinical testing.

Could Janssen have possibly missed Risperdal gynecomastia? Or did they know very well it would happen, but hid it to sell more prescriptions?

New Study on Risperdal Gynecomastia

Recently, on August 6, 2014, researchers from the University of Columbia published a study on Risperdal gynecomastia in the Journal of Clinical Psychopharmacology.

Researchers in the study reviewed the medical records of over 82,000 American men between the ages of 45 and 80. They compared data between many different types of medications, and found that Risperdal was more likely to cause gynecomastia than other antipsychotic drugs.

Of 174 men on Risperdal, 27 of them developed Risperdal gynecomastia within 2 months of taking the medication. The researchers hypothesized that some users could develop Risperdal gynecomastia within as little as 2 weeks of ingesting the drug.

That means over 15% of men aged 45-80 developed Risperdal gynecomastia within two months of taking the medication.

How does this compare to another antipsychotic?

Seroquel had another surprisingly high incidence of 10% gynecomastia cases, which is still significantly lower than the Risperdal gynecomastia risk.

The Risperdal Lawsuit

Janssen Pharmaceuticals has been to court over Risperdal many times in the past, and we anticipate they will continue to be sued over the drug, and for good cause.

The Risperdal settlement in 2013 resulted in a landmark $2.2 billion fine against the company for the unlawful marketing of the drug.

Many Risperdal gynecomastia victims have already successfully sued Janssen for medical bills, pain and suffering, and other damages.

The Risperdal lawsuit is gaining momentum as the science continues to clarify the hidden risks of the drug.

If you have been affected by Risperdal gynecomastia, we strongly recommend that you seek legal counsel to get advice on your legal rights.

We can help. At Attorneys Band Gates & Dramis we are dedicated to fighting for the rights of the wronged, and helping you get the Risperdal settlement you deserve. Our Risperdal attorneys will fight tirelessly for your rights, so you can focus on recovery.

Please call us today for a free consultation. We are so confident we will win our clients a fair Risperdal settlement, that we do not charge anything until you are paid your Risperdal settlement.

Risperdal Lawsuit Help

1-888-366-9595

Janssen Accused of Bribing Doctors

Janssen Pays Dirty Money To Doctors for Risperdal

The Risperdal lawsuits are ongoing.

The Risperdal lawsuit is multifaceted, involving:

1. Claims of injury due Risperdal gynecomastia.

2. Claims that the advertising practices were illegal.

3. Claims that Janssen gave healthcare providers illegal incentives to prescribe their drug.

The Risperdal lawsuits have been going on for over a decade now, and are quite complicated. Federal and state governments have already settled with Johnson and Johnson’s pharmaceutical division, Janssen Pharmaceuticals.

Janssen has paid billions of dollars in settlements for illegally marketing Risperdal for uses that were not FDA approved.

In addition to advertising for non-FDA approved uses, or “off-label” uses, Janssen has been accused of offering illegal incentives for doctors and healthcare providers who prescribe Risperdal.

Janssen had State Officials in Their Pocket

After being investigated by the Office of the Inspector General, Janssen was accused of bribing doctors. It was also found that Janssen was depositing checks into an account controlled by Steve Fiorello, a State chief pharmacist of Pennsylvania.

Money from this account was also being sent to the Texas Department of Mental Health and Mental Retardation.

It turns out Johnson and Johnson was funding a program called TMAP- Texas Medication Algorithm Project- which was reportedly a front for an off-label advertising project.

TMAP was flying state officials all around the country offering cushy traveling accommodations while the officials promoted the drug for off-label uses.

The motivations of TMAP are questionable at best, as Risperdal and other atypical antipsychotics are nearly 10 times the price of first generation antipsychotics, and reportedly they are more likely to cause unwanted side effects as well.

Steve Fiorello was later brought up on charges for taking money from Janssen and other pharmaceutical companies.

In addition to marketing for off-label uses, the government has also accused Johnson and Johnson of giving kickbacks to medical professionals for prescribing Risperdal.

Janssen has been accused of calling the money a “speaker fee,” when really it was a bribe for doctors who prescribed more Risperdal.

In the District of Massachusetts a complaint was made that Janssen was paying millions of dollars in bribes to Omnicare Inc., a pharmacy specialized in providing medicine to nursing homes.

Risperdal is not approved for use in the elderly, and should have never been sold to nursing homes in the first place. When taken by older adults, Risperdal becomes very dangerous and increases the chances of dying from pneumonia or heart disease.

Janssen paid Omnicare millions for prescribing Risperdal, but claimed it was for educational funding, grants market share rebate payments, etc.

Janssen intentionally paid this company to sell Risperdal and hid it by making the money look like it was for something else.

Why A Risperdal Lawsuit is Necessary

The history of Janssen paying kickbacks and illegally marketing Risperdal is a long one, and we will probably never know the full story. As more news breaks regarding the Risperdal scandal, Janssen faces increasing fines and lawsuits.

Janssen Pharmaceutical Inc., of Johnson and Johnson have been fined billions of dollars, and for good cause. They decided to do what they wanted with Risperdal, and market it aggressively, throwing ethics and caution to the wind.

While Janssen profited, the cost was high to others, causing Risperdal side effects and sometimes death. Janssen and other pharmaceutical giants cannot be allowed to continue doing business like this; something has to change.

Whistleblowers like the former employees of Janssen are helping. Whistleblowers are people who decide to turn in incriminating information about companies such as Janssen, despite the fact that it will likely kill their own career in the industry.

Plaintiffs in the current Risperdal gynecomastia lawsuit are also helping. If it weren’t for those of us fighting back against this corporation, who knows what they would do to increase profits, and at what cost.

If you or your loved one has been affected by Risperdal gynecomastia, the time to act is now. Fill out the online claims form on this page or simply call the number below:

Risperdal Lawsuit Help

1-888-366-9595

We offer a free claim evaluation to help you determine if you have a strong case in the Risperdal lawsuit. We do not charge a fee unless our Risperdal lawyers collect a fair settlement for you.

Risperdal MDL Multidistrict Litigation

The Risperdal Multidistrict Litigation – Risperdal MDL

The Risperdal lawsuits are likely to become part of a multidistrict litigation (MDL).

Meetings to organize an MDL began back in May at the Complex Litigation Center of the Philadelphia City Hall.

At that time, May of 2014, 360 Risperdal gynecomastia lawsuits had been filed.

The number of Risperdal lawsuits has nearly doubled since then; there are 662 records of pending Risperdal gynecomastia lawsuits as of today, July 28th 2014, according to Philadelphia Courts, First Judicial District of Pennsylvania.

Most of these pending Risperdal lawsuits are awaiting consolidation into the Risperdal MDL.

These claims are being petitioned for placement in what is called a multi district litigation, or an MDL.

What is an MDL?

An MDL is a way of consolidating lawsuit claims of a similar nature to be heard in a federal court by a federal judge, rather than courts and judges all over America.

When you have hundreds of claims – as is the case in the Risperdal lawsuit – MDLs can be formed to process the pretrial steps to litigation for hundreds or thousands of claimants involved.

If a case is not either dismissed or settled in the pretrial stages, the plaintiff has the right to pursue litigation. The case will then be transferred back to the district where the complaint was originally made, and go to trial.

If you are offered a pre-trial settlement, it is your right to either accept or reject it. If you chose to reject any settlement offered our Risperdal attorneys are more than prepared to litigate in court on your behalf.

How is an MDL Created?

The Plaintiffs, Defendant(s), and federal courts all have the right to petition for an MDL.

Meetings began to organize a petition for a Risperdal MDL back in May of 2014.

When an MDL is petitioned for, the request is sent to the U.S. Judicial Panel on Multidistrict Litigation (JPML). It is JPML’s responsibility to determine is an MDL is warranted, and if it is, what district and judge will hear the case.

The JPML will review the claims and decide if they are similar enough to be considered on a consolidated, “mass tort” basis.

If they believe an MDL should be created, they will assign a US District court and judge to hear the case.

There currently is no Risperdal MDL, but it’s a likely direction this case may take.

What are the benefits to an MDL?

Unlike a Risperdal class action lawsuit, a Risperdal MDL would ensure that each claim filed has the chance to be considered individually, with a chance at a fair settlement.

MDLs also save time, efforts, and expense for all parties involved- the plaintiffs, defendants, and the court system.

A Risperdal MDL would ensure that the rulings on the Risperdal lawsuit claims are consistent, by placing all the pending claims in one courtroom, to be heard by one expert US judge.

The judge will most likely appoint a Plaintiff Steering Committee, or PSC.

A PSC is a group of lawyers who are chosen to represent all the plaintiffs filing lawsuits in an MDL. Having a PSC is an advantage because your lawyer is extremely familiar with the case, and has been appointed by a US District Judge to represent you, the client, and fight for your rights against Johnson and Johnson’s attorneys.

What are the Differences between a Risperdal MDL and Risperdal Class Action Lawsuit?

In a Risperdal class action lawsuit, there would be one lawsuit filed again Janssen, and there would be one lump sum awarded if a settlement was reached.

This settlement would be divided up equally among all the hundreds, if not thousands of plaintiffs involved, without respect to their individual medical conditions caused by Risperdal side effects, which can be painful and expensive to correct.

In a Risperdal MDL the cases would have a chance to be reviewed individually by Risperdal lawyers and the judge, and if the plaintiff is in any way uncomfortable with the settlement offered, they can chose to take the case to court and litigate in a Risperdal lawsuit.

Thus, you have more control over your case in a Risperdal MDL, rather than a Risperdal class action lawsuit because you are fighting for your own individual claim and can negotiate your settlement with your Risperdal lawyer.

How We Can Help in the Risperdal MDL

Attorneys Band Gates & Dramis works both directly and indirectly with the major attorneys on the case.

As mentioned earlier, the Risperdal MDL will most likely have a Plaintiff’s Steering Committee, or PSC assigned to handle the claims. We at Consumer Claims Center of America work with members of PSCs, and intend to do so again when the Risperdal PSC is appointed.

Attorneys Band Gates & Dramis acts as an expedited claims processing center, helping you build your case and getting it reviewed by the major lawyers specialized in the Risperdal lawsuit.

If you have been affected by Risperdal Gynecomastia and think you would like to make a claim, we can help you evaluate your case with a free consultation.

Band Gates & Dramis, and the Risperdal attorneys we work with do not charge a fee for our services until you collect your Risperdal settlement.

Simply fill out the online claims form on this page, or call the number below to speak with a live representative.

Risperdal Lawsuit Help

1-888-366-9595

The Risperdal Scandal: Off-label Marketing

The Risperdal lawsuit is ongoing, and complicated.

In this article we will discuss the different charges Janssen Pharmaceuticals, the maker of Risperdal, is facing regarding illegal marketing practices with their drug Risperdal.

Janssen is putting profits over safety, putting lives at risk.

Janssen Pharmaceuticals is a subsidiary of Johnson and Johnson.

Risperdal has a long, dark history of bribery, illegal marketing, and dangerous side effects.

Risperdal is a brand name, atypical antipsychotic medication. It’s active ingredient is called risperdone.

Janssen now faces many Risperdal lawsuits, and has already plead guilty to advertising the drug for “off-label” uses.

Off-label marketing is when a company advertises for a drug to be used for purposes that are not FDA approved; they are “off the label” uses.

What are the FDA Approved Uses of Risperdal?

Originally, Risperdal was released in 1993.

At first Risperdal was only FDA approved for treating psychosis in adults with schizophrenia. Risperdal was later FDA approved for children aged 5-17 to help with the irritability associated with autism spectrum disorders.

On August 22nd, 2007, Risperdal received FDA approval to be used for treating schizophrenia in adolescents aged 13-17, and short term treatment of mania, a symptom of bipolar disorder in kids age 10 and up.

Risperdal became the first atypical antipsychotic drug to be approved to treat schizophrenia and bipolar disorder in children.

However, doctors are urged to keep in mind that Risperdal has serious side effects such as weight gain, and can cause gynecomastia in adolescent boys.

Johnson and Johnson has been sued for marketing Risperdal illegally for use with children with ADHD, persons with intellectual disability, and older adults with dementia.

Prosecutors accuse Johnson and Johnson of targeting our most vulnerable populations with what is essentially a chemical restraint.

Janssen Pharmaceuticals is also accused of down playing the risks of Risperdal, while marketing the drug for unapproved uses. This is not the first time Janssen Pharmaceuticals has gotten into trouble over Risperdal.

 Janssen Has a History of Illegally Marketing Risperdal

The current Risperdal scandal is certainly not the first: Janssen has been sued by numerous state governments for their unethical and illegal marketing of Risperdal.

Risperdal was sold illegally as a “chemical restraint” in nursing homes, putting lives at risk.

Risperdal is not approved for use with dementia in the elderly, but it has been used for such in the past.

Risperdal becomes what is known as a “chemical restraint” in a nursing home setting, ensuring that elderly residents will sleep through the night. Charges brought forth against Janssen allege that the company pitched sales to nursing homes saying they would save money by need less staff thanks to the sedative effect of Risperdal.

Former employees of Janssen Pharmaceuticals began to step forward.

They were called whistle blowers. They came forward and testified against Janssen in state court.

Former Janssen Employees Testify in Risperdal Lawsuit

Whistle blower Judy Doetterl testified that she was pressured to sell Risperdal to elder care facilities, saying that 70% of her bonus depended on it.

Doetterl knew that Risperdal was not FDA approved for use with dementia, and complained to management. Her complaints were ignored.

Doetterl wasn’t the only whistle bower to come forward; 7 others testified against Janssen for their illegal marketing of Risperdal.

Kurtis Barry, another whistle blower in the Risperdal lawsuit, was a former regional sales manager for Janssen Pharmaceuticals. He testified that the CEO of Johnson and Johnson, Alex Gorsky, knowingly and willingly directed that Risperdal be marketed to the elderly for use with dementia.

“The decision to market, promote and sell Risperdal for off-label purposes to the elderly population was made affirmatively and deliberately by defendants’ executive and management personnel, and carried out under their authority and direction.” – Kurtis Barry

The problem is, Risperdal can be deadly for the elderly. The FDA has issued a blackbox warning on Risperdal packaging warning about the risks of taking Risperdal as an older adult.

The FDA Black Box Warning on Risperdal Labels.

When given to older adults with dementia, Risperdal increases the likelihood of death from conditions such as pneumonia and stroke.

Risperdal is not, nor has it ever been approved for use with older adults with dementia.

Janssen Pays Risperdal Settlements

Janssen has lost over and over again in state courts across the nation, yet is careful not to own up to their actions, saying they agree with the principles the prosecutors are standing by, but do not feel as though they violated the law.

Janssen officials say they agree with the sentiment that medicine should only be used for FDA approved purposes, but they deny having participated in any wrong-doing regarding the marketing of Risperdal to children.

Janssen was also found to have been giving illegal and unethical incentives to doctors and hospitals to prescribe Risperdal.

Even though they deny wrong-doing in public statements, Janssen continues to plead guilty in the court room, paying billions in settlements.

The Risperdal scandal has resulted in the 3rd largest medical settlement in history.

Johnson and Johnson has been fined over $2.2 billion dollars for the inappropriate and illegal marketing of Risperdal.

The Risperdal lawsuit alleged that Janssen Pharmaceuticals illegally marketed Risperdal the the elderly and children with certain behavioral disorders.

Given that Risperdal isn’t approved for these uses, the prosecutor claimed Janssen Pharmaceuticals put some of our most vulnerable populations – children and the elderly – at risk, because Risperdal has serious side effects and can be deadly to the elderly.

Despite the large Risperdal settlement amounts being awarded on state and federal levels, Johnson and Johnson continues to profit on sales of Risperdal.

The Risperdal Gynecomastia Lawsuit

Can Janssen continue to rake in enough sales to break the law?

Janssen has been court-ordered to pay billions in Risperdal settlements, but Risperdal is still a profitable drug for Johnson and Johnson.

This is why many feel as though a lawsuit is the only way they can fight back after being manipulated and injured by a corporation like Johnson and Johnson.

We help the “little guy” fight back.

If you have been affected by Risperdal gynecomastia you have experienced pain and suffering, weight gain, hormonal imbalance, and you may have needed corrective surgery for the gynecomastia.

If you have experienced these Risperdal side effects we strongly urge you to seek legal advice, as recovering from Risperdal gynecomastia can be an expensive and painful journey.

Attorneys Band Gates & Dramis offers free, no obligation Risperdal claims evaluations.

Plaintiffs in the current Risperdal lawsuit feel as though Janssen is liable for any damages, due to the aggressive nature in which Risperdal was marketed and the fact that Janssen chose not to warn users about the possible side effect of hormonal imbalance and gynecomastia.

To begin researching your claim with Risperdal lawyers today, fill out the online form on this page or simply call the number below.

We do not charge a fee unless you collect a settlement.

Risperdal Lawsuit Help

1-888-366-9595

Risperdal Lawsuit News: Settlements Won

Settlements Reached Quickly in Early Risperdal Gynecomastia Lawsuits

The Risperdal lawsuit is in full swing, having already settled several claims. The first Risperdal lawsuit was filed on behalf of a young man who developed male breasts after taking Risperdal. It was settled on the first day of court, in September, 2012.

Five more Risperdal settlements were negotiated in state courts of Pennsylvania on October 3, 2012.

The plaintiffs alleged that Risperdal, an atypical antipsychotic medication caused them to develop male breasts, a condition known as gynecomastia.

They claim that Janssen, the pharmaceutical subsidiary of Johnson and Johnson failed to warn them about their risks of developing gynecomastia.

Plaintiffs in the Risperdal lawsuit also allege the drug was marketed for unapproved, or “off label” uses.

Janssen is being held responsible for their medical bills and pain and suffering, but the settlement amounts for the Risperdal lawsuits were not disclosed publicly.

There is speculation that the Janssen’s defense is settling before the testimony of Dr. David Kessler, a former FDA commissioner, is put on record.

Dr. Kessler has stated publicly that he believes Janssen broke the law by marketing Risperdal for unapproved, off label uses.

State Courts are Suing Johnson and Johnson for Improper Marketing

Johnson and Johnson has already been ordered to pay out hundreds of millions of dollars in Risperdal settlements to state courts.

For example Louisiana has ordered Johnson and Johnson to pay $258 million in penalties for making false claims about the safety of Risperdal.

When a manufacturer sells a drug they can only advertise it for FDA approved uses. In the case of Risperdal, claimants allege that the drug was improperly marketed for unapproved uses to both children and the elderly.

Risperdal has been found to increase mortality rates in the elderly, causing a higher risk of death due to conditions such as pneumonia and heart attack.

South Carolina courts have ordered a $327 million dollar penalty against the company for illegal marketing.

In addition to off label marketing, Johnson and Johnson is accused of giving doctors financial incentives to prescribe Risperdal.

Many other states have expressed interest in suing Johnson and Johnson for medicare reimbursement, on the basis that the company marketed it for off label uses.

 It’s the Right Time to Start Your Risperdal Lawsuit

If you have been affected by Risperdal gynecomastia, you may be eligible for compensation from a Risperdal lawsuit. The Risperdal lawsuit is currently being organized into an MDL, and over 600 individual claims are pending.

Click here to learn about the pending Risperdal MDL.

Once the Risperdal MDL is formed, a Risperdal settlement is expected to be awarded shortly after. Now is the time to find out if you qualify for a Risperdal settlement.

Fill out the online claim form on this page, or call the number below for a free consultation.

Risperdal Lawsuit Help

1-888-366-9595